Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Horning

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Blood|March 1, 1990
Detection of non-Hodgkin's lymphoma in the peripheral blood by analysis of antigen receptor gene rearrangements: results of a prospective studyS J Horning, N Galili, M Cleary, et al.
Cancer Surveys|January 1, 1985
The concept, evolution and preliminary results of the current Stanford clinical trials for Hodgkin's diseaseR T Hoppe, S J Horning, S A Rosenberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an updateS J Horning, S A Rosenberg, R T Hoppe
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Combined modality therapy for stage I-II large cell lymphomaB R Prestidge, S J Horning, R T Hoppe
International Journal of Radiation Oncology, Biology, Physics|August 1, 1996
High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survivalJ C Poen, R T Hoppe, S J Horning
Cancer|May 1, 1989
Hypercalcemia and vitamin D metabolism in Hodgkin's disease. Is there an underlying immunoregulatory relationship?J W Rieke, S S Donaldson, S J Horning
International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapyR A Behar, S J Horning, R T Hoppe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysisL W Kwak, J Halpern, R A Olshen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Long-term survival after histologic transformation of low-grade follicular lymphomaA R Yuen, O W Kamel, J Halpern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine is active in relapsed Hodgkin's diseaseJ B Lucas, S M Horwitz, S J Horning, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Blood|March 1, 1990
Detection of non-Hodgkin's lymphoma in the peripheral blood by analysis of antigen receptor gene rearrangements: results of a prospective studyS J Horning, N Galili, M Cleary, et al.
Cancer Surveys|January 1, 1985
The concept, evolution and preliminary results of the current Stanford clinical trials for Hodgkin's diseaseR T Hoppe, S J Horning, S A Rosenberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an updateS J Horning, S A Rosenberg, R T Hoppe
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Combined modality therapy for stage I-II large cell lymphomaB R Prestidge, S J Horning, R T Hoppe
International Journal of Radiation Oncology, Biology, Physics|August 1, 1996
High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survivalJ C Poen, R T Hoppe, S J Horning
Cancer|May 1, 1989
Hypercalcemia and vitamin D metabolism in Hodgkin's disease. Is there an underlying immunoregulatory relationship?J W Rieke, S S Donaldson, S J Horning
International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapyR A Behar, S J Horning, R T Hoppe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysisL W Kwak, J Halpern, R A Olshen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Long-term survival after histologic transformation of low-grade follicular lymphomaA R Yuen, O W Kamel, J Halpern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine is active in relapsed Hodgkin's diseaseJ B Lucas, S M Horwitz, S J Horning, et al.
Pageof 11